Welcome to our dedicated page for Axt SEC filings (Ticker: AXTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AXT, Inc. (AXTI) SEC filings page brings together the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer, AXT submits periodic and current reports that describe its financial condition, operations and material events related to its business of developing and manufacturing compound and single element semiconductor substrate wafers.
Through this page, investors can access annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide detailed financial statements, management discussion and analysis, and information about AXT’s substrate products based on indium phosphide, gallium arsenide and germanium. These filings also describe risk factors, business segments, manufacturing footprint in China and the role of its subsidiary Beijing Tongmei Xtal Technology Co., Ltd.
AXT’s current reports on Form 8-K document material events such as quarterly earnings announcements, preliminary revenue ranges, export control developments affecting indium phosphide and gallium arsenide shipments, capital-raising transactions under its Form S-3 shelf registration statement, and corporate governance matters including board changes and Nasdaq listing rule compliance. Some 8-Ks incorporate press releases as exhibits, giving additional context to the headline events.
Investors can also review registration statements and prospectus supplements related to AXT’s public offerings of common stock, which outline the terms of the offerings and the company’s stated use of proceeds, including plans to increase manufacturing capacity at Tongmei, fund research and development and support general corporate purposes.
On Stock Titan, AI-powered tools summarize lengthy filings, highlight key sections and help explain complex topics such as revenue drivers, export control impacts, capital structure changes and audit committee disclosures. Real-time updates from EDGAR ensure that new AXTI filings, including Forms 10-K, 10-Q, 8-K and registration-related documents, are available promptly, while insider transaction reports on Form 4 can be monitored alongside these core filings.
AXT Inc. (AXTI) reported an insider transaction on Form 4. A director sold 3,637 shares of common stock on 11/07/2025 at $8.41 per share.
Following the sale, the reporting person directly owns 118,875 shares. The filing was signed by attorney-in-fact Jeff Sensiba on 11/10/2025.
AXT, Inc. filed an S-3 shelf registration to offer up to $100,000,000 of securities from time to time after effectiveness. The mixed shelf may include common stock, preferred stock, debt securities, depositary shares, warrants, subscription rights, purchase contracts and units, with specific terms to be set in future supplements.
AXT’s common stock trades on the Nasdaq Global Select Market under the symbol AXTI. AXT states it believes no PRC central government permissions are required to complete this offering, while noting its manufacturing is conducted by PRC subsidiaries and joint ventures and highlighting related legal and operational risks. Unless otherwise specified in a supplement, net proceeds will be used for working capital and general corporate purposes. Securities may be sold directly or via agents, underwriters or dealers, with pricing determined at the time of each offering. The company does not anticipate paying cash dividends and qualifies as a smaller reporting company.
AXT Inc. (AXTI) reported an insider transaction by a director. On 11/05/2025, the director executed an open-market sale (code S) of 100,000 shares of common stock at $8.9404 per share. Following the sale, the director directly beneficially owns 207,744 shares. The filing indicates the form was submitted by one reporting person.
AXT Inc (AXTI) reported an insider transaction by its CFO. On 11/06/2025, the officer sold 22,675 shares of common stock in an open‑market transaction at a weighted average price of $8.8722.
The filing notes the sales occurred across multiple trades within a price range of $8.85 to $8.96. Following the transaction, the officer beneficially owned 463,294 shares, held directly.
AXT Inc. (AXTI) disclosed insider stock sales by its CFO. On 11/04/2025, the officer sold 27,720 shares of common stock at a weighted average price of $8.0874, leaving 538,484 shares beneficially owned directly. On 11/05/2025, a further 52,515 shares were sold at a weighted average price of $9.2088, resulting in 485,969 shares beneficially owned directly after the transactions. The sales were executed through multiple trades within stated price ranges.
AXT, Inc. (AXTI) reported insider activity by its CEO on Form 4. On 10/31/2025, the reporting person made a gift of 30,000 common shares at $0. Following this gift, 2,519,490 shares were beneficially owned directly.
On 11/03/2025, the reporting person sold 80,000 common shares at a weighted average price of $8.6481, with individual trades ranging from $8.38 to $9.16. Following this sale, 2,439,490 shares were beneficially owned indirectly by the Young Family Trust.
AXT, Inc. furnished an 8-K announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and incorporated by reference as stated.
The company notes the information in Exhibit 99.1 is being “furnished” under General Instruction B.2 and is not deemed “filed” for purposes of Section 18 of the Exchange Act or Sections 11 and 12(a)(2) of the Securities Act. It will not be incorporated by reference into other filings unless expressly stated.
AXT Inc. (AXTI) disclosed that its CEO acquired 100,000 shares of common stock on 10/28/2025 through a restricted stock grant. The award was made under the company’s 2025 Equity Incentive Plan, is exempt under Rule 16b-3, and was granted in consideration for past services, subject to a restricted stock agreement.
Following the transaction, the CEO beneficially owned 2,549,490 shares, held directly.
AXT, Inc. reported an insider equity grant. The CFO received 37,500 shares of restricted stock on October 28, 2025, reported with transaction code “A.” The award was granted under the company’s 2025 Equity Incentive Plan and is described as consideration for past services rendered, exempt under Rule 16b-3 and subject to a restricted stock agreement.
Following this grant, the reporting person beneficially owned 566,204 shares, held directly. This filing reflects a non-cash equity compensation event and does not involve an open-market purchase or sale.
AXT Inc (AXTI) reported an insider transaction by its CFO. On 10/20/2025, the officer exercised stock options for 10,280 shares at $2.18 per share (transaction code M), adding the shares to direct holdings.
After the transaction, the officer directly beneficially owned 528,704 common shares. Derivative securities beneficially owned following the event were 247,828 stock options originally granted on 11/02/2015 and expiring on 11/02/2025.